FDA/CDER to Host Roundtable Discussion on Animal Models/Immunogenicity of Therapeutic Proteins

NEEDHAM, Mass. - Aug. 22, 2013 - PRLog --  
Date: November 12, 2013
Time: 5:30-6:00 pm

Topics of discussion:
* Pros and cons of humanized mice and transgenic mice
* Time, investment and skill in getting mouse models up and running
* How to work out the appropriate dose
* Applications and recent progress with biotherapeutics: e.g. recombinant cytokines, gene therapy
* Are relative immune responses (e.g. aggregated vs. non-aggregated human protein in a mouse) a valid measure?
* How might known differences in the human and mouse adaptive and innate immune systems impact the results?

For more details, visit http://www.ImmunogenicitySummit.com

About Cambridge Healthtech Institute (chicorporate.com)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com